Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

36.60SEK
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
36.60kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
280,106
52-wk High
46.80kr
52-wk Low
23.95kr

Latest Key Developments (Source: Significant Developments)

Karo Pharma: New Issue To Provide Up To SEK 794.3 Ml‍n Before Issue Costs
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Karo Pharma Ab ::SAYS NEW ISSUE TO PROVIDE UP TO SEK 794.3 ML‍N BEFORE ISSUE COSTS.  Full Article

Karo Pharma Chairman Called For Inquiry For Inside Trading
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Karo Pharma Ab ::CHAIRMAN CALLED IN TO INQUIRY FROM POLICE FOR INSIDE TRADING.BOARD CONCLUDES THE THAT CHAIRMAN HAS ACTED CORRECTLY AND DID NOTHING WRONG, AS PER ITS INVESTIGATION.  Full Article

Karo Pharma signs agreement with Marinomed Biotech
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Karo Pharma Ab ::KARO PHARMA ANNOUNCES AGREEMENT WITH THE AUSTRIAN PHARMACEUTICAL COMPANY MARINOMED BIOTECH AG.‍WILL MARKET A PATENTED PRODUCT FOR COMMON COLD & FLU SYMPTOMS IN SWEDEN, NORWAY AND FINLAND.​.‍AGREEMENT IS LONG TERM (10 YEARS).​.  Full Article

Karo Pharma to carry out new issue
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - KARO PHARMA AB ::TO CARRY OUT NEW ISSUE WITH PROCEEDS AT ABOUT SEK 800 MILLION BEFORE ISSUE COSTS IF FULLY SUBSCRIBED.  Full Article

Karo Pharma Q3 EBITDA up at SEK ‍34.0​ mln
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - KARO PHARMA AB ::Q3 NET SALES SEK ‍137.1​ MILLION VERSUS SEK 85.2 MILLION YEAR AGO.Q3 EBITDA SEK ‍34.0​ MILLION VERSUS SEK 10.2 MILLION YEAR AGO.  Full Article

Karo Pharma Q3 EBITDA sharply up yr/yr​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Karo Pharma Ab :Says ‍net sales amounted to MSEK 418.9 (250.8), whereof Q3 MSEK 137.1 (85.2)​.Says ‍EBITDA amounted to MSEK 127.5 (22.8), whereof Q3 MSEK 34.0 (10.2)​.  Full Article

Karo Pharma says will hold more than 90 pct in Weifa ASA
Friday, 6 Oct 2017 

Oct 6 (Reuters) - Karo Pharma Ab :‍final acceptance level in karo pharma ab's voluntary offer to acquire all shares in weifa asa is 35,463,139 shares.‍karo pharma will hold more than 90% of all shares in weifa <<>>​.‍intends to initiate a compulsory acquisition of remaining outstanding shares of weifa at a price equal to offer price of nok 35 per share​.‍intends to propose that weifa applies for a delisting of its shares from oslo børs.​.  Full Article

Karo Pharma AGM approves extraordinary dividend
Thursday, 11 May 2017 

May 11 (Reuters) - Karo Pharma AB ::Says AGM approved an extraordinary dividend of SEK 0.22 per share in addition to ordinary dividend of SEK 0.28 per share.  Full Article

BRIEF-Karo Pharma says acquires Biophausia from Medivir
Tuesday, 1 Nov 2016 

Karo Pharma AB : Says acquires Biophausia (nordic brands) from Medivir .Says the purchase price will be SEK 908 million.  Full Article

Karo pharma ab says acquires biophausia (nordic brands)
Tuesday, 1 Nov 2016 

Karo Pharma AB : Says acquires Biophausia (nordic brands) from Medivir .Says the purchase price will be SEK 908 million.  Full Article

BRIEF-Karo Pharma: New Issue To Provide Up To SEK 794.3 Ml‍n Before Issue Costs

* SAYS NEW ISSUE TO PROVIDE UP TO SEK 794.3 ML‍N BEFORE ISSUE COSTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

No consensus analysis data available.